Turkey

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.43 (2.31 - 2.56) 2019 Modelled IHME
2.54 (2.41 - 2.67) 2018 Modelled IHME
2.61 (2.47 - 2.76) 2017 Modelled IHME
2.65 (2.52 - 2.78) 2016 Modelled IHME
2.68 (2.54 - 2.82) 2015 Modelled IHME
2.72 (2.59 - 2.86) 2014 Modelled IHME
2.78 (2.65 - 2.92) 2013 Modelled IHME
2.84 (2.71 - 2.99) 2012 Modelled IHME
2.91 (2.76 - 3.07) 2011 Modelled IHME
2.98 (2.82 - 3.15) 2010 Modelled IHME
3.04 (2.89 - 3.21) 2009 Modelled IHME
3.11 (2.96 - 3.28) 2008 Modelled IHME
3.18 (3.03 - 3.35) 2007 Modelled IHME
3.25 (3.09 - 3.43) 2006 Modelled IHME
3.33 (3.16 - 3.52) 2005 Modelled IHME
3.41 (3.24 - 3.59) 2004 Modelled IHME
3.49 (3.32 - 3.68) 2003 Modelled IHME
3.57 (3.39 - 3.77) 2002 Modelled IHME
3.66 (3.46 - 3.88) 2001 Modelled IHME
3.75 (3.53 - 3.99) 2000 Modelled IHME
3.85 (3.61 - 4.09) 1999 Modelled IHME
3.95 (3.71 - 4.19) 1998 Modelled IHME
4.05 (3.80 - 4.29) 1997 Modelled IHME
4.14 (3.88 - 4.40) 1996 Modelled IHME
4.22 (3.95 - 4.50) 1995 Modelled IHME
4.29 (4.02 - 4.57) 1994 Modelled IHME
4.35 (4.09 - 4.62) 1993 Modelled IHME
4.41 (4.16 - 4.68) 1992 Modelled IHME
4.46 (4.19 - 4.74) 1991 Modelled IHME
4.5 (4.22 - 4.79) 1990 Modelled IHME
3 2003 Survey/reported Ozsoy MF et al, 2003
2.5 2009 Survey/reported Akcama FZ et al, 2009
2.63 (2.08 - 3.28) 2015 Modelled WHO
2.6 (1.90 - 3.50) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.17 (0.14 - 0.20) 2019 Modelled IHME
0.18 (0.15 - 0.21) 2018 Modelled IHME
0.19 (0.16 - 0.23) 2017 Modelled IHME
0.2 (0.17 - 0.24) 2016 Modelled IHME
0.21 (0.18 - 0.25) 2015 Modelled IHME
0.22 (0.19 - 0.26) 2014 Modelled IHME
0.24 (0.20 - 0.27) 2013 Modelled IHME
0.25 (0.21 - 0.29) 2012 Modelled IHME
0.27 (0.22 - 0.31) 2011 Modelled IHME
0.29 (0.24 - 0.34) 2010 Modelled IHME
0.33 (0.27 - 0.38) 2009 Modelled IHME
0.38 (0.32 - 0.45) 2008 Modelled IHME
0.45 (0.38 - 0.53) 2007 Modelled IHME
0.53 (0.44 - 0.63) 2006 Modelled IHME
0.62 (0.52 - 0.73) 2005 Modelled IHME
0.73 (0.61 - 0.85) 2004 Modelled IHME
0.85 (0.72 - 1) 2003 Modelled IHME
1 (0.85 - 1.18) 2002 Modelled IHME
1.17 (0.99 - 1.38) 2001 Modelled IHME
1.37 (1.16 - 1.63) 2000 Modelled IHME
1.69 (1.43 - 1.98) 1999 Modelled IHME
2.15 (1.81 - 2.50) 1998 Modelled IHME
2.63 (2.20 - 3.06) 1997 Modelled IHME
3.03 (2.52 - 3.53) 1996 Modelled IHME
3.25 (2.69 - 3.81) 1995 Modelled IHME
3.34 (2.79 - 3.92) 1994 Modelled IHME
3.42 (2.85 - 4) 1993 Modelled IHME
3.47 (2.90 - 4.09) 1992 Modelled IHME
3.51 (2.92 - 4.16) 1991 Modelled IHME
3.52 (2.93 - 4.16) 1990 Modelled IHME
0.32 (0.22 - 0.48) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
2,690,620 (2,525,260 - 2,864,160) 1990 Modelled IHME
2,715,720 (2,554,160 - 2,889,220) 1991 Modelled IHME
2,732,440 (2,575,450 - 2,901,910) 1992 Modelled IHME
2,741,770 (2,575,750 - 2,912,060) 1993 Modelled IHME
2,744,390 (2,570,970 - 2,921,980) 1994 Modelled IHME
2,741,130 (2,565,370 - 2,922,170) 1995 Modelled IHME
2,728,100 (2,555,650 - 2,901,830) 1996 Modelled IHME
2,703,390 (2,539,790 - 2,868,990) 1997 Modelled IHME
2,670,910 (2,512,990 - 2,832,450) 1998 Modelled IHME
2,634,580 (2,476,340 - 2,799,080) 1999 Modelled IHME
2,598,600 (2,447,770 - 2,767,210) 2000 Modelled IHME
2,562,930 (2,424,370 - 2,715,550) 2001 Modelled IHME
2,526,390 (2,396,010 - 2,666,310) 2002 Modelled IHME
2,489,450 (2,367,180 - 2,622,940) 2003 Modelled IHME
2,450,910 (2,331,050 - 2,585,790) 2004 Modelled IHME
2,411,980 (2,293,430 - 2,553,280) 2005 Modelled IHME
2,374,050 (2,259,900 - 2,503,660) 2006 Modelled IHME
2,336,860 (2,224,450 - 2,465,400) 2007 Modelled IHME
2,299,600 (2,186,130 - 2,422,420) 2008 Modelled IHME
2,261,500 (2,145,420 - 2,388,720) 2009 Modelled IHME
2,225,320 (2,106,660 - 2,355,990) 2010 Modelled IHME
2,193,170 (2,082,480 - 2,311,920) 2011 Modelled IHME
2,166,680 (2,062,490 - 2,280,870) 2012 Modelled IHME
2,148,900 (2,047,560 - 2,261,330) 2013 Modelled IHME
2,135,240 (2,035,280 - 2,246,690) 2014 Modelled IHME
2,122,900 (2,018,890 - 2,236,210) 2015 Modelled IHME
2,119,510 (2,017,390 - 2,226,130) 2016 Modelled IHME
2,107,620 (1,993,640 - 2,226,650) 2017 Modelled IHME
2,058,040 (1,955,760 - 2,161,460) 2018 Modelled IHME
1,976,310 (1,881,680 - 2,082,750) 2019 Modelled IHME
2,091,000 (1,536,000 - 2,786,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.34 (3.25 - 5.68) 2019 Modelled IHME
4.26 (3.26 - 5.53) 2018 Modelled IHME
4.24 (3.31 - 5.40) 2017 Modelled IHME
4.36 (3.51 - 5.40) 2016 Modelled IHME
4.52 (3.72 - 5.47) 2015 Modelled IHME
4.53 (3.77 - 5.41) 2014 Modelled IHME
4.51 (3.77 - 5.39) 2013 Modelled IHME
4.51 (3.76 - 5.34) 2012 Modelled IHME
4.55 (3.80 - 5.39) 2011 Modelled IHME
4.55 (3.76 - 5.40) 2010 Modelled IHME
4.66 (3.87 - 5.56) 2009 Modelled IHME
4.84 (3.96 - 5.84) 2008 Modelled IHME
5.07 (4.10 - 6.20) 2007 Modelled IHME
5.3 (4.29 - 6.49) 2006 Modelled IHME
5.45 (4.45 - 6.66) 2005 Modelled IHME
5.61 (4.59 - 6.83) 2004 Modelled IHME
5.8 (4.80 - 7.05) 2003 Modelled IHME
6.07 (5.14 - 7.21) 2002 Modelled IHME
6 (5.05 - 7.11) 2001 Modelled IHME
6.04 (5.09 - 7.10) 2000 Modelled IHME
6.38 (5.33 - 7.50) 1999 Modelled IHME
6.56 (5.40 - 7.76) 1998 Modelled IHME
6.66 (5.51 - 7.93) 1997 Modelled IHME
6.67 (5.44 - 7.91) 1996 Modelled IHME
6.75 (5.43 - 8.03) 1995 Modelled IHME
6.74 (5.40 - 8.08) 1994 Modelled IHME
6.65 (5.30 - 8) 1993 Modelled IHME
6.57 (5.19 - 7.92) 1992 Modelled IHME
6.5 (5.09 - 7.90) 1991 Modelled IHME
6.39 (4.96 - 7.86) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,530 (2,645 - 4,618) 2019 Modelled IHME
3,454 (2,642 - 4,483) 2018 Modelled IHME
3,417 (2,670 - 4,353) 2017 Modelled IHME
3,494 (2,812 - 4,329) 2016 Modelled IHME
3,583 (2,953 - 4,337) 2015 Modelled IHME
3,557 (2,955 - 4,247) 2014 Modelled IHME
3,490 (2,913 - 4,164) 2013 Modelled IHME
3,434 (2,862 - 4,072) 2012 Modelled IHME
3,427 (2,864 - 4,060) 2011 Modelled IHME
3,404 (2,813 - 4,037) 2010 Modelled IHME
3,464 (2,875 - 4,131) 2009 Modelled IHME
3,581 (2,930 - 4,316) 2008 Modelled IHME
3,726 (3,011 - 4,560) 2007 Modelled IHME
3,869 (3,135 - 4,740) 2006 Modelled IHME
3,950 (3,228 - 4,832) 2005 Modelled IHME
4,035 (3,301 - 4,912) 2004 Modelled IHME
4,140 (3,425 - 5,029) 2003 Modelled IHME
4,292 (3,632 - 5,097) 2002 Modelled IHME
4,198 (3,535 - 4,974) 2001 Modelled IHME
4,181 (3,527 - 4,920) 2000 Modelled IHME
4,371 (3,648 - 5,135) 1999 Modelled IHME
4,437 (3,652 - 5,254) 1998 Modelled IHME
4,452 (3,678 - 5,296) 1997 Modelled IHME
4,395 (3,588 - 5,210) 1996 Modelled IHME
4,382 (3,525 - 5,215) 1995 Modelled IHME
4,311 (3,453 - 5,171) 1994 Modelled IHME
4,193 (3,342 - 5,038) 1993 Modelled IHME
4,073 (3,215 - 4,912) 1992 Modelled IHME
3,957 (3,101 - 4,811) 1991 Modelled IHME
3,819 (2,966 - 4,696) 1990 Modelled IHME
4,200 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
42 (34 - 51) 2019 Modelled IHME
42 (34 - 51) 2018 Modelled IHME
42 (34 - 51) 2017 Modelled IHME
42 (35 - 51) 2016 Modelled IHME
43 (35 - 51) 2015 Modelled IHME
43 (35 - 51) 2014 Modelled IHME
43 (35 - 51) 2013 Modelled IHME
44 (36 - 52) 2012 Modelled IHME
44 (36 - 53) 2011 Modelled IHME
45 (37 - 54) 2010 Modelled IHME
45 (37 - 54) 2009 Modelled IHME
46 (38 - 54) 2008 Modelled IHME
47 (39 - 56) 2007 Modelled IHME
48 (40 - 57) 2006 Modelled IHME
49 (41 - 58) 2005 Modelled IHME
49 (41 - 58) 2004 Modelled IHME
49 (41 - 57) 2003 Modelled IHME
48 (40 - 57) 2002 Modelled IHME
48 (40 - 57) 2001 Modelled IHME
48 (40 - 57) 2000 Modelled IHME
48 (40 - 57) 1999 Modelled IHME
49 (40 - 57) 1998 Modelled IHME
49 (40 - 58) 1997 Modelled IHME
49 (40 - 58) 1996 Modelled IHME
49 (40 - 58) 1995 Modelled IHME
49 (40 - 58) 1994 Modelled IHME
49 (41 - 58) 1993 Modelled IHME
49 (40 - 58) 1992 Modelled IHME
49 (40 - 58) 1991 Modelled IHME
49 (40 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
97 2010 Survey/reported WHO/UNICEF
96 2009 Survey/reported WHO/UNICEF
96 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
94 2005 Survey/reported WHO/UNICEF
88 2004 Survey/reported WHO/UNICEF
78 2003 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
96 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
97 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
94 2009 Survey/reported WHO/UNICEF
92 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
82 2006 Survey/reported WHO/UNICEF
85 2005 Survey/reported WHO/UNICEF
77 2004 Survey/reported WHO/UNICEF
68 2003 Survey/reported WHO/UNICEF
72 2002 Survey/reported WHO/UNICEF
77 2001 Survey/reported WHO/UNICEF
71 2000 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.99 (0.82 - 1.23) 2019 Modelled IHME
0.84 (0.68 - 1.01) 2018 Modelled IHME
0.77 (0.63 - 0.91) 2017 Modelled IHME
0.78 (0.66 - 0.91) 2016 Modelled IHME
0.79 (0.68 - 0.92) 2015 Modelled IHME
0.79 (0.68 - 0.91) 2014 Modelled IHME
0.78 (0.68 - 0.90) 2013 Modelled IHME
0.77 (0.67 - 0.88) 2012 Modelled IHME
0.76 (0.66 - 0.87) 2011 Modelled IHME
0.75 (0.66 - 0.86) 2010 Modelled IHME
0.74 (0.65 - 0.84) 2009 Modelled IHME
0.73 (0.64 - 0.82) 2008 Modelled IHME
0.71 (0.63 - 0.81) 2007 Modelled IHME
0.7 (0.61 - 0.80) 2006 Modelled IHME
0.69 (0.61 - 0.79) 2005 Modelled IHME
0.69 (0.60 - 0.79) 2004 Modelled IHME
0.69 (0.59 - 0.79) 2003 Modelled IHME
0.69 (0.59 - 0.80) 2002 Modelled IHME
0.68 (0.58 - 0.80) 2001 Modelled IHME
0.68 (0.58 - 0.80) 2000 Modelled IHME
0.69 (0.59 - 0.81) 1999 Modelled IHME
0.71 (0.60 - 0.83) 1998 Modelled IHME
0.73 (0.61 - 0.86) 1997 Modelled IHME
0.76 (0.63 - 0.90) 1996 Modelled IHME
0.78 (0.65 - 0.95) 1995 Modelled IHME
0.81 (0.67 - 0.99) 1994 Modelled IHME
0.85 (0.70 - 1.04) 1993 Modelled IHME
0.89 (0.73 - 1.09) 1992 Modelled IHME
0.93 (0.76 - 1.15) 1991 Modelled IHME
0.98 (0.79 - 1.21) 1990 Modelled IHME
0.6 (0.30 - 1) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1 2009 Survey/reported Zeynep F et al, 2008.
0.3 2003 Survey/reported Ozsoy MF et al, 2003
1 (0.60 - 2.10) 2014 Survey/reported Gower et al, 2014
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
44.9 (41.70 - 48.20) 2015 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
584,672 (475,107 - 723,112) 1990 Modelled IHME
567,254 (463,279 - 702,815) 1991 Modelled IHME
550,335 (450,027 - 677,710) 1992 Modelled IHME
534,629 (438,745 - 654,507) 1993 Modelled IHME
520,800 (427,924 - 631,530) 1994 Modelled IHME
509,533 (419,957 - 616,450) 1995 Modelled IHME
498,875 (416,089 - 594,902) 1996 Modelled IHME
487,793 (409,994 - 576,785) 1997 Modelled IHME
478,445 (403,905 - 561,629) 1998 Modelled IHME
473,044 (400,841 - 554,286) 1999 Modelled IHME
473,908 (400,253 - 555,099) 2000 Modelled IHME
478,964 (407,930 - 557,378) 2001 Modelled IHME
484,708 (416,134 - 562,375) 2002 Modelled IHME
490,947 (423,335 - 565,669) 2003 Modelled IHME
497,141 (430,823 - 568,447) 2004 Modelled IHME
503,188 (438,866 - 574,654) 2005 Modelled IHME
511,550 (448,560 - 582,220) 2006 Modelled IHME
523,458 (459,765 - 594,592) 2007 Modelled IHME
536,995 (471,714 - 609,707) 2008 Modelled IHME
550,178 (482,981 - 623,911) 2009 Modelled IHME
561,853 (491,526 - 639,488) 2010 Modelled IHME
574,008 (500,927 - 653,449) 2011 Modelled IHME
588,582 (511,934 - 672,149) 2012 Modelled IHME
604,606 (523,560 - 695,628) 2013 Modelled IHME
618,792 (533,047 - 714,142) 2014 Modelled IHME
627,989 (538,863 - 726,963) 2015 Modelled IHME
623,885 (526,744 - 727,548) 2016 Modelled IHME
618,120 (508,274 - 731,010) 2017 Modelled IHME
677,324 (554,988 - 815,901) 2018 Modelled IHME
808,638 (664,031 - 999,651) 2019 Modelled IHME
492,000 (271,000 - 763,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.22 (2.35 - 4.29) 2019 Modelled IHME
3.16 (2.33 - 4.10) 2018 Modelled IHME
3.1 (2.33 - 4.04) 2017 Modelled IHME
2.96 (2.25 - 3.76) 2016 Modelled IHME
2.85 (2.20 - 3.53) 2015 Modelled IHME
2.84 (2.24 - 3.49) 2014 Modelled IHME
2.82 (2.23 - 3.48) 2013 Modelled IHME
2.8 (2.23 - 3.49) 2012 Modelled IHME
2.8 (2.24 - 3.52) 2011 Modelled IHME
2.77 (2.20 - 3.46) 2010 Modelled IHME
2.69 (2.10 - 3.38) 2009 Modelled IHME
2.57 (1.94 - 3.26) 2008 Modelled IHME
2.42 (1.83 - 3.09) 2007 Modelled IHME
2.32 (1.75 - 2.95) 2006 Modelled IHME
2.28 (1.73 - 2.91) 2005 Modelled IHME
2.32 (1.76 - 2.97) 2004 Modelled IHME
2.38 (1.81 - 2.99) 2003 Modelled IHME
2.49 (1.93 - 3.06) 2002 Modelled IHME
2.45 (1.91 - 3) 2001 Modelled IHME
2.44 (1.87 - 2.99) 2000 Modelled IHME
2.55 (1.93 - 3.18) 1999 Modelled IHME
2.62 (1.94 - 3.29) 1998 Modelled IHME
2.64 (1.97 - 3.33) 1997 Modelled IHME
2.62 (1.92 - 3.34) 1996 Modelled IHME
2.65 (1.93 - 3.39) 1995 Modelled IHME
2.67 (1.89 - 3.44) 1994 Modelled IHME
2.68 (1.89 - 3.49) 1993 Modelled IHME
2.71 (1.89 - 3.57) 1992 Modelled IHME
2.77 (1.88 - 3.65) 1991 Modelled IHME
2.83 (1.89 - 3.74) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
2,624 (1,910 - 3,491) 2019 Modelled IHME
2,558 (1,891 - 3,326) 2018 Modelled IHME
2,501 (1,883 - 3,262) 2017 Modelled IHME
2,371 (1,804 - 3,012) 2016 Modelled IHME
2,258 (1,742 - 2,802) 2015 Modelled IHME
2,225 (1,756 - 2,739) 2014 Modelled IHME
2,181 (1,722 - 2,691) 2013 Modelled IHME
2,131 (1,700 - 2,656) 2012 Modelled IHME
2,114 (1,689 - 2,654) 2011 Modelled IHME
2,071 (1,644 - 2,587) 2010 Modelled IHME
2,003 (1,564 - 2,516) 2009 Modelled IHME
1,898 (1,438 - 2,413) 2008 Modelled IHME
1,777 (1,348 - 2,272) 2007 Modelled IHME
1,691 (1,277 - 2,151) 2006 Modelled IHME
1,651 (1,253 - 2,112) 2005 Modelled IHME
1,668 (1,267 - 2,139) 2004 Modelled IHME
1,701 (1,294 - 2,130) 2003 Modelled IHME
1,757 (1,364 - 2,162) 2002 Modelled IHME
1,713 (1,334 - 2,096) 2001 Modelled IHME
1,688 (1,293 - 2,070) 2000 Modelled IHME
1,750 (1,322 - 2,178) 1999 Modelled IHME
1,770 (1,314 - 2,228) 1998 Modelled IHME
1,763 (1,313 - 2,222) 1997 Modelled IHME
1,730 (1,265 - 2,202) 1996 Modelled IHME
1,725 (1,254 - 2,201) 1995 Modelled IHME
1,709 (1,209 - 2,201) 1994 Modelled IHME
1,686 (1,192 - 2,201) 1993 Modelled IHME
1,680 (1,172 - 2,215) 1992 Modelled IHME
1,688 (1,145 - 2,224) 1991 Modelled IHME
1,689 (1,127 - 2,238) 1990 Modelled IHME
2,492 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
28 (21 - 35) 2019 Modelled IHME
28 (21 - 35) 2018 Modelled IHME
28 (21 - 35) 2017 Modelled IHME
28 (21 - 34) 2016 Modelled IHME
27 (20 - 34) 2015 Modelled IHME
27 (21 - 34) 2014 Modelled IHME
27 (21 - 34) 2013 Modelled IHME
27 (20 - 34) 2012 Modelled IHME
27 (20 - 33) 2011 Modelled IHME
26 (20 - 33) 2010 Modelled IHME
26 (19 - 33) 2009 Modelled IHME
26 (19 - 33) 2008 Modelled IHME
25 (19 - 31) 2007 Modelled IHME
24 (18 - 30) 2006 Modelled IHME
23 (17 - 30) 2005 Modelled IHME
23 (17 - 29) 2004 Modelled IHME
24 (17 - 30) 2003 Modelled IHME
24 (17 - 30) 2002 Modelled IHME
24 (17 - 31) 2001 Modelled IHME
24 (17 - 30) 2000 Modelled IHME
24 (17 - 30) 1999 Modelled IHME
24 (17 - 30) 1998 Modelled IHME
24 (17 - 31) 1997 Modelled IHME
24 (17 - 31) 1996 Modelled IHME
24 (17 - 31) 1995 Modelled IHME
24 (17 - 31) 1994 Modelled IHME
24 (17 - 31) 1993 Modelled IHME
24 (18 - 31) 1992 Modelled IHME
24 (17 - 31) 1991 Modelled IHME
24 (17 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
2.43 (%)
2019
(2.31 - 2.56(%))
IHME
HCV (RNA/cAg+)
0.99 (%)
2019
(0.82 - 1.23(%))
IHME

Survey/surveillance

HBV (HBsAg+)
2.5 (%)
2009
Akcama FZ et al, 2009
HCV (anti-HCV)
1 (%)
2014
(0.6 - 2.1(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
3,530
2019
(2,645 - 4,618)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2,624
2019
(1,910 - 3,491)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.17 (%)
2019, latest modelled
(0.14 - 0.20(%))
IHME

Prevalence PWID

HCV
44.90 (%)
2015, latest modelled
(41.70 - 48.20(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Action plan

View all

Action plans

Resources

Programs